- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05018312
Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety (CO-ASSM-RCT)
Social Phobia and Evasiveness: A Feasibility, Superiority, Randomized Clinical Trial of the Effect of Modified Collaborative Assessment VS Standard Assessment on Patient's Readiness For Psychotherapy (CO-ASSM-RCT)
Study Overview
Status
Intervention / Treatment
Detailed Description
The present study wish to compare the preliminarily effects and feasibility of Modified Collaborative Assessment (MCA) - a novel therapeutic approach to diagnostic assessment - with assessment-as-usual (AAU) among patients with evasiveness as a core psychopathological feature in a randomised controlled study design.
The study will include and randomise 42 patients 1:1 to either MCA or AAU, which will be administered as a pre-treatment to the standard psychotherapeutic intervention they will receive in the psychotherapeutic clinic.
MCA will utilize standardised psychological tests administered in collaboration with the patients, in order to thorough diagnose the included patients. The tests available will be the Present State Examination (PSE), the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD), the Screen for Cognitive Impairment in Psychiatry (SCIP), the Autism Diagnostic Observation Schedule (ADOS-2), the Examination of anomalous self-experience (EASE), the Wechsler Adult Intelligence Scale (WAIS-IV), the Level of Personality Functioning - Brief Form 2.0 (LPFS-BF), the Personality Inventory for DSM-5, 36 item version (PID-36) and the Conners´ Adult ADHD Rating Scales (CAARS).
Data are gathered through a number of questionnaires from patients prior to randomization (T0), at end of MCA (T1) and after four weeks of psychotherapy (T2) - absolute time depend on clinical logistics and timing of group therapy onset.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sjælland
-
Maribo, Sjælland, Denmark, 4930
- Psykiatrisk Klinik Maribo
-
Næstved, Sjælland, Denmark, 4700
- Psykiatrisk Klinik Næstved
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A tentative ICD-10 diagnosis of either SAD or EPD
- Going to be offered treatment in the psychiatric community clinics in Naestved, Maribo or Slagelse
Exclusion Criteria:
- Severe physical health problems.
- Lack of spoken and written danish corresponding to 9th grade primary school.
- Eating disorder with BMI < 18
- Psychotic illness
- Active diagnosis of substance abuse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Modified Collaborative Assessment (MCA)
The patients allocated to this arm will receive assessment inspired by therapeutic/collaborative assessment, as a pre-treatment to the standard psychotherapeutic treatment they will receive in the clinic.
|
The Modified Collaborative Assessment (MCA) will be assessment of the patients that Is more thoroughly-done, and which will be inspired by the school of Therapeutic Assessment and Collaborative Assessment.
It will include the EASE, SCID-interview, PSE, ADOS and SCIP-interviews.
|
Active Comparator: Assessment as usual (AAU)
The patients allocated to this arm will receive standard assessment offered in the clinic, before proceeding to the standard psychotherapeutic treatment they will receive in the clinic.
|
Assessment as usual is the standard assessment the patients will receive in the clinic.
It includes one or more interviews with a mental health professional in the clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
University of Rhode Island Change Assessment Scale (URICA)
Time Frame: Baseline T0 (Week 1 after allocation) and T1 (end of intervention, an average of four weeks after allocation)
|
The URICA is a 32-item self-report measure that includes 4 subscales measuring the motivation for change: Precontemplation, Contemplation, Action, and Maintenance.
The minimum score is 32 and maximum value is 160.
A higher score indicate that the patient is more ready to making changes in their life, compared to a lower.
|
Baseline T0 (Week 1 after allocation) and T1 (end of intervention, an average of four weeks after allocation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Liebowitz Social Anxiety Scale-Self- Report (LSAS)
Time Frame: Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
The 24-item LSAS-SR, includes questions pertaining to social interaction and performance situations.
The LSAS-SR have shown to have good convergent, discriminant validity, and reliability.
The minimum score is 48 and maximum value is 144.
A higher score indicate that the patient have greater problems with anxiety, compared to a lower.
|
Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rosenberg Self-Esteem Scale (RSES)
Time Frame: Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
The RSES is a 10-item measure of self-esteem that includes five positive items and five negative items which are reversed scored (Rosenberg, 1965). In general, the RSES has demonstrated good convergent validity and good test-retest reliability and in similar populations of adults with social phobia, the RSES has demonstrated high internal consistency. The minimum score is 10 and maximum value is 40. A higher score indicate that the patient has a better self-esteem, compared to a lower. |
Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
General Self-Efficacy Scale (GSES)
Time Frame: Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
The GSE is a 10-item psychometric scale that is designed to a ssess optimistic self-beliefs to cope with a variety of difficult demands in life. In contrast to other scales that were designed to assess optimism, this one explicitly refers to personal agency, i.e., the belief that one's actions are responsible for successful outcomes. The minimum score is 10 and maximum value is 40. A higher score indicate that the patient feels better suited to handle difficult situations, compared to a lower. |
Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
Working Alliance Inventory (WAI)
Time Frame: T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
The WAI is a 12-item psychometric questionnaire that is designed to assess the therapeutic alliance between a patient and a therapist. The questionaire isn't scored. |
T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
Client Satisfaction Questionnaire (CSQ-8)
Time Frame: T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
The CSQ-8 is a self-report questionnaires constructed to measure satisfaction with services received by individuals and families. The minimum score is 8 and maximum value is 32. A higher score indicate that the patient is more satisfied with the treatment, compared to a lower. |
T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)
|
National Patient Reported Outcome Measures (PROM)- Psychiatry
Time Frame: Baseline T0 (end of intervention, an average of four weeks after allocation); T1 (end of intervention) and T2 (after one month psychotherapy)
|
The Danish National PROM is a 19-item, self-report measure covering patients own view on their mental and physical health, and level of general well-being. The minimum score is 19 and maximum value is 114. A higher score indicate that the patient is less burdened by his/her symptoms, compared to a lower. |
Baseline T0 (end of intervention, an average of four weeks after allocation); T1 (end of intervention) and T2 (after one month psychotherapy)
|
Purpose-made questionary on specific feasibility-outcomes
Time Frame: T1 (end of intervention, an average of four weeks after allocation)
|
We intend to - for the purpose of this trial - construct questionnaires evaluating the patients' and clinicians´ evaluation of the intervention.
|
T1 (end of intervention, an average of four weeks after allocation)
|
Readiness for Psychotherapy Index
Time Frame: Baseline T0 (Week 1 after allocation) and T1 (end of intervention, an average of four weeks after allocation)
|
The RPI is a 20-item self-report measure that uses a 5-point Likert scale to assess 7 dimensions of readiness for psychotherapy: level of distress, desire for change, willingness to work in therapy, recognition of problems as psychological, willingness to discuss personal matters, willingness to endure discomfort in therapy, and responsibility for change. The questionnaire will be translated and validated for use in a Danish mental health service population. The minimum score is 20 and maximum value is 100. A higher score indicate that the patient is less ready to participate in psychotherapy, compared to a lower. |
Baseline T0 (Week 1 after allocation) and T1 (end of intervention, an average of four weeks after allocation)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sidse Arnfred, MD PhD DMSc, Research Unit for Psychotherapy and Psychopathology, Psychiatry West, Region Zealand MHS
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Personality Disorders
-
Icahn School of Medicine at Mount SinaiCompletedBorderline Personality Disorders | Avoidant Personality DisordersUnited States
-
University Hospital, Basel, SwitzerlandLeading House for the Latin American Region (Seed Money Grant SMG 1730)WithdrawnBorderline Personality Disorder (BPD)
-
University of Colorado, DenverCompleted
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
-
NHS Greater Glasgow and ClydeUnknownBorderline Personality Disorder (BPD) | Antisocial Personality Disorder (ASPD)United Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingBorderline Personality Disorders | BPDSpain
-
Hospital Universitari Vall d'Hebron Research InstituteUnknownBorderline Personality Disorder.Spain
-
Universidad Nacional Autonoma de MexicoCompletedPsychopathic Personality TraitMexico
-
Silvia Elisa Hurtado SantiagoCompletedPersonality Disorder, BorderlineSpain
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
Clinical Trials on Modified Collaborative Assessment (MCA)
-
University of WashingtonAmerican Foundation for Suicide Prevention; The Catholic University of AmericaCompletedQuality of Life | Suicidal Ideation | Suicide, Attempted | Distress, Psychological
-
The Catholic University of AmericaUniversity of Washington; VA Office of Research and DevelopmentCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation Active
-
Yuzuncu Yıl UniversityUnknownIschemia | Sudden Hearing Loss
-
Duke UniversityNational Institute of Mental Health (NIMH)RecruitingSuicideUnited States
-
Carevive Systems, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Evidence-Based Practice Institute, Seattle, WACompletedDepression | Insomnia | SuicideUnited States
-
Kaiser PermanenteCompletedChest Pain | Acute Coronary Syndrome | Risk ReductionUnited States
-
Hospital Universitario Doctor PesetRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaSpain
-
Seattle Children's HospitalNationwide Children's HospitalRecruitingSuicidal Ideation | Suicide Threat | Suicide and Self-harm | Suicide AttemptsUnited States
-
Ottawa Heart Institute Research CorporationCompletedCoronary Artery DiseaseCanada